Cytokeratin 19 antibody
Quick Overview for Cytokeratin 19 antibody (ABIN1724421)
Target
See all Cytokeratin 19 (KRT19) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Reacts with human Cytokeratin 19
-
Cross-Reactivity (Details)
- Does not react with hepatocytes and hepatocellular carcinoma.
-
Purification
- Purified
-
Immunogen
- Cytoskeletal preparation of human bladder carcinoma cell line T24
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Working dilution: FC (1:100 - 1:200), ICC, IHC - F (1:100 - 1:200), IHC-P (10 μg/mL), WB (1:100 - 1:1000)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 0.09 % Sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted.
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Alternative Name
- Cytokeratin 19
-
UniProt
- P08727
Target
-